Sorrento Therapeutics Inc (SRNE) stock is higher by 47.94% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary scoring system, gives SRNE stock a score of 62 out of a possible 100.
That score is mainly influenced by a fundamental score of 85. In addition to the average rating from Wall Street analysts, SRNE stock has a mean target price of 25.5. This means analysts expect the stock to climb 545.57% over the next 12 months. SRNE's score also includes a long-term technical score of 55. The short-term technical score for SRNE is 46.
What's Happening with SRNE Stock Today
Sorrento Therapeutics Inc (SRNE) stock has gained 4.64% while the S&P 500 is higher by 0.03% as of 1:41 PM on Wednesday, Dec 11. SRNE is higher by $0.18 from the previous closing price of $3.78 on volume of 5,207,903 shares. Over the past year the S&P 500 has gained 18.84% while SRNE is higher by 47.94%. SRNE lost -$2.25 per share in the over the last 12 months.